5-S-cysteinyldopa as a tumor marker for primary uveal malignant melanoma

Journal of Japanese Ophthalmological Society

Volumn 102, Issue 5, 1998, Pages 319-326

  Goto, Hiroshi ^a   Tenou, Tomoko ^a   Kudo, Hitoshi ^a   Iwasaki, Takuya ^a   Muramatsu, Ryuji ^a   Usui, Masahiko ^a   Wakamatsu, Kazumasa ^b   Ito, Shosuke ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

5 S CD; Tumor marker; Uveal melanoma

Indexed keywords

BIOCHEMICAL MARKER; CYSTEINYLDOPA; TUMOR MARKER;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; TISSUE LEVEL; UVEA MELANOMA; VITREOUS BODY;

ADULT; AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; CYSTEINYLDOPA; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS; VITREOUS BODY;

EID: 0031781808     PISSN: 00290203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. 121 I]-iodoamphetamine. Clin Nucl Med 10 : 415-417, 1985.
2. Folberg R, Augsburger JJ, Gamel JW, Shields JA, Lang WR : Fine-needle aspirates of uveal melanomas and prognosis. Am J Ophthalmol 100 : 654-657, 1985.
3. Peyman GA , Apple DJ : Local excision of choroidal malignant melanoma. Full-thickness eye wall resection. Arch Ophthalmol 92 : 216-218, 1974.
4. Horikoshi T, Ito S, Wakamatsu K, Onodera H, Eguchi H : Evaluation of melanin-related metabolites as markers of melanoma progression. Cancer 73 : 629-636. 1994
5. Ye Zushou, Kageshita T, Ishihara T, Ito S, Ono S:A case of malignant melanoma : Disease progression correlated with serum levels of 5-S-cysteinyldopa (5-S-CD) and intercellular adhesion molecule- 1 (ICAM-1). J Dermatol 22 : 370-375. 1995.
6. Wakamatsu K, Ito S, Horikoshi T : Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxy-indole-2-carboxylic acid, biochemical markers of melanoma progression. Melanoma Res 1 : 141-147. 1991.
7. Hilton GF, Gizzard WS : Pneumatic retinopexy. A two-step outpatient operation without conjunctival incision. Ophthalmology 93 : 626-641. 1986.
8. Wakamatsu K, Ito S : Improved HPLC determination of 5-S-cysteinyldopa in serum Clin Chem 40: 495-496, 1994.
9. Zimmerman LE, MaClean IW, Foster WD : Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells ? Br J Ophthalmol 62 : 420-425, 1978.
10. Ito S, Wakamatsu K : Melanin chemistry and melanin precursors in melanoma. J Invest Dermatol 62 : 261-265, 1989.
11. Ito S : Melanin-related metabolites as markers of melanoma : A review. J Dermatol 19 : 802 -805. 1992.
12. Mason HS : The chemistry of melanin. III. Mechanism of the oxidation of dihydroxyphenylalanine by tyrosinase. J Biol Chem 172 : 83-99, 1948.
13. Horikoshi T, Ito S : Serum 5-S-cysteinyldopa(5-S -CD) as a marker of melanoma progression. J Dermatol 19 : 809-813, 1992.